FDA Newsfeed
Choose content
Create your own custom newsfeed
|
Set preferences
Set up your newsfeed details, look and feel and desired output
|
Create account
Enter your registration information
|
-
2025 Reshaped the FDA. What Will 2026 Hold?
09 Feb 2026 05:29 GMT
BioSpace
… Review Amidst Staffing Losses FDA Commissioner Marty Makary … review efficiency. The FDA has since announced multiple … transparency” push, the FDA began releasing complete response … Negotiations: Negotiations between the FDA and industry representatives over …
-
FDA Policy Tracker 2026: Priority Vouchers Questioned, PRVs Return
09 Feb 2026 05:29 GMT
BioSpace
… in lost revenue. _________________________________________________________________________ FDA Launches PreCheck Manufacturing Program … process will be. _________________________________________________________________________ FDA Positions New Endpoints for …
-
<![CDATA[Ultragenyx Puts BLA for MPS IIIA Gene Therapy UX111 in Front of FDA Again]]>
09 Feb 2026 02:30 GMT
NeurologyLive
… granted priority review by the FDA in February 2025, and … MPS IIIA) to U.S. FDA. News release. Ultragenyx Pharmaceutical Inc … receives complete response letter from FDA for UX111 AAV gene … ultragenyx-receives-complete-response-letter-fda-ux111-aav-gene 3. …
-
Former FDA Commissioner Warns US Measles Surge Part Of Global Cycle
09 Feb 2026 04:14 GMT
Ommcom News
Washington: Former US Food and Drug Administration commissioner Dr. Scott Gottlieb warned that the accelerating measles outbreak in the United States is part of a broader global cycle driven by falling vaccination rates and a growing anti-vaccine backlash …
-
<![CDATA[FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care ]]>
09 Feb 2026 01:06 GMT
OncLive
… with dihydropyrimidine dehydrogenase (DPD) deficiency. FDA. February 5, 2026. Accessed … -information-approved-drugs/fda-approves-safety-labeling-changes-regarding … injection-products Xeloda. Prescribing information. FDA. Updated December 2022. Accessed …
-
<![CDATA[FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL]]>
09 Feb 2026 01:06 GMT
OncLive
… /refractory PCNSL. The FDA’s decision was supported by … of neurologic AEs, the FDA concluded that the overall safety … release. “We appreciate the FDA’s timely review and decision … for long-term surveillance. References FDA approves label update for Kite …
- FDA updates food dye guidance, promotes natural ingredients 08 Feb 2026 21:58 GMT Fox News
-
Hims & Hers (HIMS) Shares Sink 16% as FDA Crackdown Halts Wegovy Copycat Pill
08 Feb 2026 17:29 GMT
Markets Insider
… comment right away, and the FDA also declined to add details … (LLY) have argued that the FDA has not done enough to …
-
Hims & Hers Halts Compounded Semaglutide Pill Offering After FDA's Crackdown Warning
08 Feb 2026 13:48 GMT
Benzinga
… healthcare to millions of Americans. FDA's Warning On Friday … .S. Food and Drug Administration (FDA) warned that it intends to … ) intended for use in non-FDA-approved compounded drugs that are … from drugs for which the FDA cannot verify quality, safety, or …
-
Hims Withdraws GLP-1 Weight Loss Pill After FDA Warning and Lawsuit Threats
08 Feb 2026 13:14 GMT
AOL
… ? A whole lot of drama. FDA Came Down Hard on Hims … are not approved by the FDA. The day after Hims… ; announcement, the FDA came down hard, announcing it … a few months after the FDA gave the company a warning …
-
Don’t risk your health on unapproved aphrodisiacs – FDA warns youth
08 Feb 2026 10:13 GMT
GhanaWeb
The Food and Drugs Authority (FDA) has issued a warning to … , Head of Communications at the FDA, highlighted the rising abuse of … illegal manufacturers and importers. The FDA urged the public to exercise …
- Aurobindo Pharma formulations facility gets 11 observations from FDA 08 Feb 2026 05:52 GMT ETPharma.com
-
Telehealth company scraps plans to sell cheap GLP-1 diet pill after FDA vows crackdown
08 Feb 2026 03:49 GMT
New York Post
… Novo Nordisk. REUTERS The FDA vowed to take swift action … Department of Justice. “[The FDA will] use all available compliance … associated public health concerns,” FDA Commissioner Marty Makary said in … dropped 14% Friday after the FDA’s announcement. “No one …
-
Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats
08 Feb 2026 03:05 GMT
FOX Business
… the Food and Drug Administration (FDA) that it would take … to this treatment." The FDA named checked Hims & Hers … from drugs for which the FDA cannot verify quality, safety, … Hims’ shares fell after the FDA announcement on Friday. PFIZER CEO …
-
Hims & Hers halts sale of Wegovy copycat after FDA crackdown on weight-loss
08 Feb 2026 02:16 GMT
Mint
… Food and Drug Administration (US FDA), which is “cracking down on … company. The next day, the FDA announced its investigation. The Department … a request for comment. The FDA declined to comment. Novo, … Eli Lilly push US FDA for firm action against weight …
-
Hims cancels plans to sell compounded GLP-1 pill after FDA backlash
08 Feb 2026 01:26 GMT
BioPharma Dive
… lawsuits and warnings from the FDA, those efforts have continued … social media post Thursday, FDA commissioner Martin Makary threatened “ … A day later, the FDA announced it would “take … as “similar alternatives” to FDA-approved medications. The Department for …
-
Hims Drops Fat-Loss Pill After FDA Warning
08 Feb 2026 00:56 GMT
Daily Wire
… the telehealth firm said. The FDA said on Friday that it … the losses on Friday after FDA Commissioner Dr. Marty Makary tweeted … Hims’ compounded drug is not FDA-approved and has not gone … concerns.” HHS, which oversees the FDA, was not immediately available for …
-
M&M Recall: FDA Issues High Risk Warning On Thousands Of Repackaged Candies In 20 States
08 Feb 2026 00:26 GMT
Blavity
… agency, according to an FDA news release obtained by AllRecipes … Independent. On Wednesday, the FDA issued a classification of the … food allergens identified by the FDA; the others include eggs, … called anaphylaxis, per the FDA. Symptoms of allergic reactions …
- Hims & Hers abandons copycat weight-loss drug in face of FDA probe 07 Feb 2026 21:59 GMT Yahoo Finance
-
Hims to stop offering GLP-1 pill after FDA warned of crackdown
07 Feb 2026 20:13 GMT
WKZO - Michigan
… ,” the telehealth firm said. The FDA said on Friday that it … the losses on Friday after FDA Commissioner Dr. Marty Makary tweeted … . Hims’ compounded drug is not FDA-approved and has not gone …
-
Hims & Hers to stop offering compounded semaglutide pill after FDA crackdown
07 Feb 2026 19:27 GMT
Yahoo Finance
Feb 7 (Reuters) - Hims & Hers said in a statement on Saturday that it will stop offering access to the compounded semaglutide pill after the U.S. Food and Drug Administration said it would take action against the telehealth provider for its …
-
Hims & Hers Tanks After FDA Signals Tighter GLP-1 Rules
07 Feb 2026 15:57 GMT
Wall Street Pit
… of Wegovy, while the FDA emphasized that compounded products … options compared to FDA-authorized therapies. The FDA’s initiative … practices, according to the FDA, improperly suggest that compounded … reflect the lack of FDA validation. Further escalating the …
-
Taiwan FDA warns against misuse of weight loss drugs
07 Feb 2026 12:29 GMT
Focus Taiwan
Taipei, Feb. 7 (CNA) The Taiwan Food and Drug Administration (TFDA) on Saturday asked the public to refrain from procuring GLP-1 and GIP weight-loss medications from unknown sources, after the United Kingdom issued a heightened warning about the drugs last …
-
Ipca Laboratories receives US FDA VAI status for Tarapur API facility
07 Feb 2026 08:21 GMT
Business Upturn
… Food and Drug Administration (US FDA) for its Active Pharmaceutical Ingredients … update follows a routine US FDA inspection conducted at the … EIR) issued by the US FDA, the Tarapur manufacturing facility has … status indicates that the US FDA does not intend to …
-
In the Super Bowl of Drug Ads, Trump’s FDA Plays the Long Game for Patients
07 Feb 2026 05:22 GMT
Townhall
… the Food and Drug Administration (FDA) about whether their ads provided … and leadership. Recently, the FDA has made clear that it … faced the brunt of the FDA’s offensive against healthcare advertising … to align itself with the FDA’s broader message that …



About